Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported):  November 16, 2011
 
STAAR Surgical Company
 
(Exact name of registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction
of incorporation)
0-11634
(Commission File Number)
95-3797439
(I.R.S. Employer
Identification No.)
     
1911 Walker Ave, Monrovia, California
(Address of principal executive offices)
  
91016
(Zip Code)

Registrant’s telephone number, including area code:                626-303-7902
 
Not Applicable
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 7.01 Regulation FD Disclosure.
 
STAAR Surgical Company’s President and Chief Executive Officer, Barry Caldwell, will make a presentation at the Stephens Fall Investment Conference at the New York Palace Hotel in New York City on Wednesday, November 16, 2011 at 9:00 a.m.  A copy of the slide presentation Mr. Caldwell will use in his presentation is furnished as Exhibit 99.1 to this Report, and is incorporated herein by this reference.
 
STAAR will offer a live video webcast of its presentation on the Company’s website, www.staar.com, under “Investor Information.”  An archived replay of the presentation will be available for 30 days, also at www.staar.com.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
November 16, 2011
 STAAR Surgical Company  
       
 
By:
/s/ Barry Caldwell  
    Barry Caldwell  
   
President and Chief Executive Officer
  
 
Exhibit Index
 
Exhibit No.
  
Description                                                   
99.1
  
Slide Presentation dated November 16, 2011.